Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319459649> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4319459649 endingPage "107180" @default.
- W4319459649 startingPage "107180" @default.
- W4319459649 abstract "To assess cost-effectiveness of sclerotherapy for venous malformations (VMs) to improve patient quality of life (QOL).This prospective study enrolled 28 patients with symptomatic VMs who underwent sclerotherapy. EuroQol-5 Dimension (EQ-5D) and Short-Form 36 (SF-36) Health Survey were used to measure health-related QOL. Questionnaires were collected before and 1, 3, 6, and 12 months after sclerotherapy. Quality-adjusted life years (QALYs) were calculated using EQ-5D score as a measure of health utility. Medical costs obtained from the hospital accounting system and other costs of staff, drugs, materials, and angiographic equipment were calculated for each procedure. Cost-effectiveness was analyzed using incremental cost-effectiveness ratio (ICER) as the medical cost/gain of QALYs.Median EQ-5D scores improved from 0.768 (range, 0.705–1) to 1 (range, 0.768–1) after 6 months (P = .023) and 1 (range, 0.768–1) after 12 months (P = .063). The gain of QALYs at 12 months was 0.043. The mean medical cost was ¥281,228 ($2,337). The pain group (baseline bodily pain scale of SF-36 score < 70) showed greater improvement in median EQ-5D score, from 0.705 (range, 0.661–0.768) to 0.768 (range, 0.705–1) after 6 months (P = .041) and 0.768 (range, 0.768–1) after 12 months (P = .049). ICER at 12 months was ¥6,600,483 ($54,840) in the overall group and decreased to ¥3,998,113 ($33,218) in the pain group, < ¥6,000,000 ($49,850), threshold for acceptance of a public health benefit in Japan, even accounting for 50% increase in costs.Sclerotherapy was cost-effective for improving QOL for symptomatic VMs, especially for patients with moderate to severe pain." @default.
- W4319459649 created "2023-02-09" @default.
- W4319459649 creator A5009957481 @default.
- W4319459649 creator A5032904426 @default.
- W4319459649 creator A5039961705 @default.
- W4319459649 creator A5066035783 @default.
- W4319459649 creator A5081531955 @default.
- W4319459649 date "2023-02-01" @default.
- W4319459649 modified "2023-09-25" @default.
- W4319459649 title "Single-centre prospective clinical and procedural analysis identifying causes of delay to haematopoietic stem cell transplant in MPS I (Hurler syndrome) patients" @default.
- W4319459649 doi "https://doi.org/10.1016/j.ymgme.2022.107180" @default.
- W4319459649 hasPublicationYear "2023" @default.
- W4319459649 type Work @default.
- W4319459649 citedByCount "0" @default.
- W4319459649 crossrefType "journal-article" @default.
- W4319459649 hasAuthorship W4319459649A5009957481 @default.
- W4319459649 hasAuthorship W4319459649A5032904426 @default.
- W4319459649 hasAuthorship W4319459649A5039961705 @default.
- W4319459649 hasAuthorship W4319459649A5066035783 @default.
- W4319459649 hasAuthorship W4319459649A5081531955 @default.
- W4319459649 hasConcept C112930515 @default.
- W4319459649 hasConcept C126322002 @default.
- W4319459649 hasConcept C141071460 @default.
- W4319459649 hasConcept C159110408 @default.
- W4319459649 hasConcept C1862650 @default.
- W4319459649 hasConcept C187212893 @default.
- W4319459649 hasConcept C188816634 @default.
- W4319459649 hasConcept C2778230777 @default.
- W4319459649 hasConcept C2778464720 @default.
- W4319459649 hasConcept C2779134260 @default.
- W4319459649 hasConcept C2779951463 @default.
- W4319459649 hasConcept C3019006561 @default.
- W4319459649 hasConcept C3019080777 @default.
- W4319459649 hasConcept C515549039 @default.
- W4319459649 hasConcept C71924100 @default.
- W4319459649 hasConceptScore W4319459649C112930515 @default.
- W4319459649 hasConceptScore W4319459649C126322002 @default.
- W4319459649 hasConceptScore W4319459649C141071460 @default.
- W4319459649 hasConceptScore W4319459649C159110408 @default.
- W4319459649 hasConceptScore W4319459649C1862650 @default.
- W4319459649 hasConceptScore W4319459649C187212893 @default.
- W4319459649 hasConceptScore W4319459649C188816634 @default.
- W4319459649 hasConceptScore W4319459649C2778230777 @default.
- W4319459649 hasConceptScore W4319459649C2778464720 @default.
- W4319459649 hasConceptScore W4319459649C2779134260 @default.
- W4319459649 hasConceptScore W4319459649C2779951463 @default.
- W4319459649 hasConceptScore W4319459649C3019006561 @default.
- W4319459649 hasConceptScore W4319459649C3019080777 @default.
- W4319459649 hasConceptScore W4319459649C515549039 @default.
- W4319459649 hasConceptScore W4319459649C71924100 @default.
- W4319459649 hasIssue "2" @default.
- W4319459649 hasLocation W43194596491 @default.
- W4319459649 hasOpenAccess W4319459649 @default.
- W4319459649 hasPrimaryLocation W43194596491 @default.
- W4319459649 hasRelatedWork W1509473538 @default.
- W4319459649 hasRelatedWork W1935902567 @default.
- W4319459649 hasRelatedWork W2154362091 @default.
- W4319459649 hasRelatedWork W2190757990 @default.
- W4319459649 hasRelatedWork W2294922625 @default.
- W4319459649 hasRelatedWork W2310170993 @default.
- W4319459649 hasRelatedWork W2528233585 @default.
- W4319459649 hasRelatedWork W2973108776 @default.
- W4319459649 hasRelatedWork W4230349629 @default.
- W4319459649 hasRelatedWork W4378574200 @default.
- W4319459649 hasVolume "138" @default.
- W4319459649 isParatext "false" @default.
- W4319459649 isRetracted "false" @default.
- W4319459649 workType "article" @default.